Literature DB >> 856554

Early detection of chronic obstructive pulmonary disease using radionuclide lung-imaging procedures.

G V Taplin, D P Tashkin, S K Chopra, O E Anselmi, D Elam, B Calvarese, A Coulson, R Detels, S N Rokaw.   

Abstract

One hundred subjects answered a respiratory questionnaire and underwent a physical examination, tests of pulmonary function, and three radionuclide lung-imaging procedures. The results of the radionuclide procedures were compared with each other and with pulmonary function tests and other diagnostic findings to determine their relative sensitivity for detecting evidence of early obstructive airway disease. Perfusion lung imaging was less sensitive than most of the other diagnostic tests evaluated. The aerosol and xenon lung-imaging procedures revealed abnormalities with approximately the same frequency as each other, but more often than any one group of pulmonary function tests, including spirometric data, maximal expiratory flow-volume curves, alveolararterial oxygen gradient, or indices derived from single-breath nitrogen washout. We concluded that xenon and aerosol lung-imaging studies are sensitive and useful screening procedures for detecting evidence of early localized obstructive airway disease and for locating regional abnormalities in the airways of patients with respiratory disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856554     DOI: 10.1378/chest.71.5.567

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

1.  A rapid method for the evaluation of diagnostic radioaerosol delivery systems.

Authors:  P Phipps; P Borham; I Gonda; D Bailey; G Bautovich; S Anderson
Journal:  Eur J Nucl Med       Date:  1987

2.  Role of radio-aerosol and perfusion lung imaging in early detection of chronic obstructive lung disease.

Authors:  A Garg; P G Gopinath; J N Pande; J S Guleria
Journal:  Eur J Nucl Med       Date:  1983

3.  Effects of acute and long-term bronchodilator treatment on regional lung function in asthma assessed with krypton-81m and technetium-99m-labelled macroaggregates.

Authors:  A R Sovijärvi; L Pöyhönen; L Kellomäki; A Muittari
Journal:  Thorax       Date:  1982-07       Impact factor: 9.139

4.  Imaging sites of airway obstruction and measuring functional responses to bronchodilator treatment in asthma.

Authors:  S K Chopra; G V Taplin; D P Tashkin; E Trevor; D Elam
Journal:  Thorax       Date:  1979-08       Impact factor: 9.139

5.  Ventilation/perfusion SPECT in chronic obstructive pulmonary disease: an evaluation by reference to symptoms, spirometric lung function and emphysema, as assessed with HRCT.

Authors:  Jonas Jögi; Marie Ekberg; Björn Jonson; Gracijela Bozovic; Marika Bajc
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-02       Impact factor: 9.236

6.  Bronchiectasis in childhood. Comparison of chest roentgenograms, bronchography and lung scintigraphy.

Authors:  J Vandevivere; M Spehl; I Dab; D Baran; A Piepsz
Journal:  Pediatr Radiol       Date:  1980-07

7.  Evaluation of alveolar permeability and lung ventilation in patients with chronic renal failure using Tc-99m DTPA radioaerosol inhalation lung scintigraphy.

Authors:  C H Kao; Y H Hsu; S J Wang
Journal:  Lung       Date:  1996       Impact factor: 2.584

8.  Krypton-81m and 5-micron radioaerosol images in asymptomatic asthma: a blind marking assessment.

Authors:  J E Agnew; E J Wood; P P Sutton; J R Bateman; D Pavia; S W Clarke
Journal:  Eur J Nucl Med       Date:  1984

9.  Combined Assessment of Pulmonary Ventilation and Perfusion with Single-Energy Computed Tomography and Image Processing.

Authors:  Yukio Fujita; Michael Kent; Erik Wisner; Lynelle Johnson; Joshua Stern; Lihong Qi; John Boone; Tokihiro Yamamoto
Journal:  Acad Radiol       Date:  2020-06-10       Impact factor: 3.173

10.  Quantitative lung SPECT applied on simulated early COPD and humans with advanced COPD.

Authors:  Pernilla Norberg; Hans Lennart Persson; Gudrun Alm Carlsson; Björn Bake; Magnus Kentson; Michael Sandborg; Agnetha Gustafsson
Journal:  EJNMMI Res       Date:  2013-04-19       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.